	US 11,833,181 B1
	Method of treating or preventing Alzheimer's Disease
Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); Mai Mostafa Khalaf Ali, Al-Ahsa (SA); Ahmed Mohammed Abu-Dief Mohammed, Al-Ahsa (SA); Hazem Mohamed Shaheen, Al-Ahsa (SA); Gaber Elsaber Abd El-Wanis Batiha, Al-Ahsa (SA); Manal Aly Shalaby, Al-Ahsa (SA); and Amany Mabrouk Abd Elhady Alamh, Al-Ahsa (SA)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Jun. 26, 2023, as Appl. No. 18/214,019.
Int. Cl. A61K 36/28 (2006.01); A61K 9/51 (2006.01)

CPC A61K 36/28 (2013.01) [A61K 9/5169 (2013.01)]

11 Claims

1. A method of treating Alzheimer's disease (AD) in a subject, comprising administering to a subject in need thereof a therapeutically effective amount of a nanocomposite formulation and a pharmaceutically acceptable carrier, the nanocomposite formulation including silymarin nanoparticles encapsulated within a collagen-based-polymeric nanoparticulate drug delivery system.